Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain

Key facts

Sponsor

Johns Hopkins University

Principal Investigator

Srinivasa N Raja, MD

Johns Hopkins University

Intervention

Transdermal Fentanyl(drug)

Enrollment

53 enrolled

Eligibility

18-75 years · All sexes

Timeline

2003 – 2005

Collaborators

PriCara, Unit of Ortho-McNeil, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for OBSOLETE: Acquired metabolic neuropathy

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07496398
  Median and Ulnar Nerve Function in Tattoo Artists
  Gazi University
• ENROLLING BY INVITATIONNANCT07126197
  Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy
  National Taiwan University Hospital
• RECRUITINGNANCT07095998
  Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy
  Ka-Wai Ho
• RECRUITINGPHASE2NCT07036796
  Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy
  Ain Shams University
• RECRUITINGNCT06483620
  Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire
  Cairo University
• RECRUITINGNANCT06158529
  High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain
  Fan BiFa
• RECRUITINGNANCT06287736
  Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
  Ohio State University
• RECRUITINGNANCT06488963
  The Effect of Cold Therapy on Peripheral Neuropathy
  Koç University

See all trials for OBSOLETE: Acquired metabolic neuropathy →